@dalts66
Correct.. 1st and 2nd patients for Phase1 were dosed in September and October last year before the IPO. So we are pretty much on schedule to have more data readouts on completion of subsequent dose escalation cohorts.
Frankly, it’s a fairly big positive to me since nothing negative after initial dosing 7 months ago.
Fingers crossed. IMO, this may become another multi bagger for me from Paul Hopper.
As usual, we are coming to you. Patients, Just hang in there !
Ann: Successful Completion of First Patient Cohort Phase 1 Trial, page-26
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $50.77K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2602327 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 15.15pm 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |